ADVERTISEMENT

Conference Report

ESC 2022 —Will aspirin stick around in the fight against cardiovascular disease?

Shrabasti Bhattacharya   |   31 August 2022

In an interesting debate session at the European Society of Cardiology (ESC) 2022, Dr Carlos Aguiar (Hospital Santa Cruz, Lisbon, Portugal) and Dr John Cleland (University of Glasgow, Glasgow, United Kingdom of Great Britain & Northern Ireland) argued whether to use aspirin in primary and secondary cardiovascular disease (CVD) prevention....

          

November Challenge

Ends in 1d 5h
left
right

Topic Challenges

left
right